SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

Taysha Gene Therapies Q1 EPS $(0.87) Misses $(0.56) Estimate

Taysha Gene Therapies (NASDAQ:TSHA) reported quarterly losses of $(0.87) per share which missed the analyst consensus estimate of $(0.56) by 55.36 percent.

05/11/2021 07:11
Taysha Gene Therapies (NASDAQ:TSHA) reported quarterly losses of $(0.87) per share which missed the analyst consensus estimate of $(0.56) by 55.36 percent.